A 46-year-old 
Introduction

Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor of intermediate behavior that can arise from various sites, including the liver, spleen, bone, soft tissue, and lungs (1-7). EHE usually affects adult women, and its malignant potential ranges between benign hemangioma and obviously malignant hemangioendotheliosarcoma (5-7). The clinical progression of EHE is usually slow. Here, we report a patient with rapidly progressive disease involving the liver and lungs with fatal outcome 4 months after symptom onset.
Case Report
A 46-year-old woman was admitted to hospital with a 3-month history of gradually increasing general fatigue and pain in the right upper quadrant. She had undergone a hysterectomy due to uterine myoma at 45 years of age, but had no other history of abnormal laboratory or chest X-ray findings. Laboratory examinations on admission revealed liver dysfunction and chest X-ray showed pleural effusion on the left side (Fig. 1). A few days after admission
F i g u r e 2 . Ch e s t X-r a y s h o we d i n c r e a s e d l e f t p l e u r a l e f f u s i o n c o mp a r e d wi t h t h a t d e t e c t e d i n t h e f i r s t h o s p i t a l a n d i n f i l t r a t i v e s h a d o w i n b o t h l o we r l u n g f i e l d s ( a )
. Ch e s t CT s c a n s h o wi n g mu l t i p l e a n d n o d u l e s wi t h d i a me t e r s r a n g i n g f r o m 3 t o 2 0 mm i n b o t h l u n g s ( b ) a n d p l e u r a l e f f u s i o n o n t h e l e f t s i d e ( c ) .
F i g u r e 3 . Ab d o mi n a l CT s c a n s h o we d h e p a t o me g a l y a n d a d i f f u s e l y e x p a n d e d l o w-d e n s i t y a r e a i n r i g h t a n t e r i o r s e gme n t o f t h e l i v e r .
sion compared with the findings at the hospital she initially attended seven days previously (Fig. 2a) . Chest computed tomography (CT) revealed multiple nodules with diameters ranging from 3 to 20 mm with ground-glass opacity in both lung fields suggesting the presence of pulmonary edema (Fig. 2b) . In addition, increased left pleural effusion was observed (Fig. 2c) . Abdominal CT confirmed hepatomegaly and revealed areas of low density in the right anterior segment of the liver (Fig. 3) Fig. 4a and b) . Histological and immunohistochemical staining showed that the tumor cells were positive for the endothelial marker factor VIIIrelated antigen and CD31 (Fig. 4c and d, 
F i g u r e 4 . P a t h o l o g i c a l f i n d i n g s f r o m o p e n l i v e r n e c r o p s y . ( a ) Mi c r o s c o p y s h o we d s l i g h t l y p l e omo r p h i c n e o p l a s t i c c e l l s wi t h r o u n d e d n u c l e i a n d s c a n t c y t o p l a s m o c c a s i o n a l l y a r r a n g e d i n v a s c ul a r c h a n n e l s . T h e c y t o p l a s m i n c l u d e d ma n y v a c u o l e s c o n t a i n i n g e r y t h r o c y t e s ( He ma t o x y l i n a n d E os i n s t a i n i n g ; × 4 0 0 ) . ( b ) P a r t i a l n e c r o s i s o f t h e t u mo r ( He ma t o x y l i n a n d E o s i n s t a i n i n g , × 2 0 0 ) . ( c ) T u mo r c e l l s i mmu n o s t a i n e d wi t h a n t i b o d y t o f a c t o r VI I I -r e l a t e d a n t i g e n ( f a c t o r VI I I -r e l a t e d a n t ig e n ; × 1 0 0 ) a n d ( d ) CD3 1 ( × 1 0 0 ) .
F i g u r e 5 . Ma l i g n a n t c e l l s i n p l e u r a l e f f u s i o n i mmu n o s t a i n e d wi t h a n t i b o d y t o CD3 1 ( × 6 0 ) .
factor VIII-related antigen and CD31, respectively). A diagnosis of EHE was made based on these findings. In addition, malignant cells in the pleural effusion were also positive for CD31 (Fig. 5). These findings indicated that the patient died as a result of EHE involving the liver and pleura.
Discussion
We described a case of hepatic EHE with rapid progression and fatal outcome. In this case, multiple pulmonary metastasis and DIC were associated with the initial clinical presentation. Weiss and Enzinger proposed the term EHE in 1982 to describe a group of 41 soft tissue vascular tumors of endothelial origin (1). The clinical course of the disease was highly variable and intermediate between benign hemangioma and angiosarcoma (1). The liver is an important site of EHE, but EHE has also been identified in other sites, including the spleen, bone, soft tissue, and lungs (1-7). The etiology and pathogenic factors of this tumor remain unknown (6).
Hepatic (2, 6, 7) .
The radiological features of hepatic EHE have been discussed in several reviews (8, 9) (9, 10 
. The tumor begins as hepatic nodules that grow and coalesce, forming large confluent masses preferentially involving the liver periphery. Extensive hepatic involvement is associated with enlargement of uninvolved portions of the liver and splenomegaly (8). Furui et al suggested that nodular lesions may be an earlier form of hepatic EHE, as they gradually become diffuse (9). Mehrabi et al reported that the majority of patients had enhancement, whereas no enhancement and irregular enhancement were the other reported patterns (7). In addition, the metastatic rate during the clinical course of hepatic EHE is 27% (6). The most frequent site is the lung at a rate of 81%, followed by abdominal lymph nodes (39%), omentum and mesentery (31%) in patients with EHE (6). The most characteristic feature in metastatic pulmonary lesions on chest radiograph or CT images is the presence of multiple nodules with well-or ill-defined margins ranging up to 2 cm in diameter
